1. Al Alawi AM, Nordenström A, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency. Endocrine. 2019;63:407–21.
2. Alswailem MM, Alzahrani OS, Alhomaidah DS, Alasmari R, Qasem E, Murugan AK, et al. Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population. Mol Cell Endocrinol. 2018;461:105–11.
3. Donadille B, Houang M, Netchine I, Siffroi JP, Christin-Maitre S. Human 3-beta-hydroxysteroid dehydrogenase deficiency associated with normal spermatic numeration despite a severe enzyme deficit. Endocr Connect. 2018;7:395–402.
4. Güven A, Polat S. Testicular adrenal rest tumor in two brothers with a novel mutation in the 3-beta-hydroxysteroid dehydrogenase-2 gene. J Clin Res Pediatr Endocrinol. 2017;9(1):85.
5. Johannsen TH, Mallet D, Dige-Petersen H, Müller J, Main KM, Morel Y, et al. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2005;90:2076–80.